摘要
探讨新型抗肿瘤药物JR6诱导人结肠癌细胞HT-29凋亡机制.使用噻唑兰比色法(MTT)检测JR6对人结肠癌细胞HT-29的生长抑制作用,并测定HT-29细胞中超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、过氧化氢酶(CAT)的活性和丙二醛(MDA)浓度.JR6对HT-29细胞生长有明显抑制作用,可以降低HT-29细胞中SOD、GSH-Px、CAT活性,升高MDA浓度.JR6对HT-29细胞有明显的细胞毒作用,其IC50为39.8μg/mL,可能通过影响HT-29细胞中SOD、GSH-Px、CAT活性和MDA浓度,达到诱导HT-29细胞凋亡的目的.
To investigate the mechanism of a new antitumor medicine JR6 on apoptosis in human colon cancer cell HT-29. Using thiazolyl blue colorimetry(MTT) to detect the growth inhibition of JR6 on human colon cancer HT-29 cells. HT-29 cells are collected for measurement of the activity of SOD,GSH-Px,CAT and the content of MDA. JR6 has significant growth inhibition on HT-29 cells. It can reduce the activity of SOD,GSH-Px,CAT,increase the content of MDA in HT-29 cells. JR6 has significant cytotoxicity on HT-29 cells. The IC50 is 39.8 μg/mL. It may induce apoptosis through the effect on the activity of SOD,GSH-Px,CAT and the content of MDA in HT-29 cells.
出处
《哈尔滨商业大学学报(自然科学版)》
CAS
2009年第6期649-651,656,共4页
Journal of Harbin University of Commerce:Natural Sciences Edition
基金
国家自然科学基金项目(30873090)